WE GIVE SHAREHOLDERS A VOICE

Intellipharmaceutics International Inc. Loss Submission Form

Levi & Korsinsky, LLP announces it has filed a class action complaint in the USDC for the Southern District of New York on behalf of shareholders of Intellipharmaceutics International Inc. (NASDAQ: IPCI) who purchased shares between May 21, 2015 and July 26, 2017.

The complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Intellipharmaceutics failed to conduct a human abuse liability study to support its Rexista New Drug Application (“NDA”); (2) the Company did not include abuse-deterrent studies conducted to support abuse-deterrent label claims related to abuse of the drug by various pathways; (3) the Company was not submitting sufficient data to support approval of the NDA; and (4) as a result, Defendants’ statements about Intellipharmaceutics’ business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

On July 27, 2017, shares of Intellipharmaceutics fell when the FDA released a report disclosing that “The safety information collected in the pharmacokinetic studies was of limited value…”

If you suffered a loss in Intellipharmaceutics you have until September 29, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

To receive more information, please fill out the form.

SEE IF YOU QUALIFY FOR MONETARY REWARD

Levi & Korsinsky, LLP doesn't share your information with others. There is no cost or obligation to submit. Your submission does NOT establish an attorney-client relationship.

This submission does not create an attorney-client relationship. If we believe that you might be an appropriate lead plaintiff, we will contact you to discuss whether to establish an attorney-client relationship.

TOLL FREE:: 877-363-5972
FAX:: 212-363-7171

Joseph E. Levi Founding Partner

Joseph E. Levi, Founding Partner

Mr. Levi is a central figure in shaping and managing the Firm’s securities litigation practice. In addition to his efforts on behalf of shareholders, he has represented numerous patent holders in enforcing their patent rights.
Eduard Korsinsky Founding Partner

Eduard Korsinsky, Founding Partner

Mr. Korsinsky is a Managing Partner of the Firm. He has served as an Editor of the American Bar Association’s Securities Litigation Section newsletter. He represents clients in securities cases, derivative actions, consumer fraud and complex commercial matters.
Donald J. Enright Partner

Donald J. Enright, Partner

Mr. Enright’s practice focuses on shareholder mergers and acquisitions and securities fraud class action litigation. He has also handled matters in commodities, consumer fraud, and commercial litigation. He has served in a leadership role in numerous actions, yielding multi-million dollar recoveries for shareholder classes.
Shannon L. Hopkins Partner

Shannon L. Hopkins, Partner

Ms. Hopkins manages the Firm’s Connecticut office. She has prosecuted a wide range of class action matters for over a decade, helping to recover millions in settlements on behalf of shareholders. Ms. Hopkins is also a Certified Public Accountant.
Nicholas I. Porritt Partner

Nicholas I. Porritt, Partner

Mr. Porritt prosecutes securities class actions, shareholder class actions, derivative actions, and mergers and acquisitions litigations. As a qualified Solicitor of the Senior Courts of England & Wales, he advises international clients on the recovery of losses suffered in their investment portfolios.
Nancy A. Kulesa Partner

Nancy A. Kulesa, Partner

Ms. Kulesa’s practice focuses on securities litigation and institutional investor relations. She directs the Firm’s Portfolio Monitoring Services, assisting clients in identifying losses in their securities portfolios that were caused by corporate wrongdoing.

THE POWERHOUSE

$522M In re Google Inc. Class C Shareholder Litigation
In re Google Inc. Class C Shareholder Litigation resulted in a payment of $522 million to shareholders and overall benefit of over $3 billion to Google’s minority shareholders.
$79M Freudenberg v. E*TRADE Financial Corp., et al., 07 CV 8538 (S.D.N.Y. 2007), Co-Lead Counsel
Selected from a crowded field as Co-Lead Counsel, we achieved a landmark $79 million common fund settlement for the benefit of E*Trade’s shareholders in an action relating to the misrepresentation of the risk associated with E*Trade’s investment in subprime mortgage-backed securities.
$36.5M In re Bluegreen Corp. S’holder Litigation, Case No. 502011CA018111 (Circuit Court for Palm Beach County, Florida), Co-Lead Counsel
Achieved a $36.5 million common fund settlement for former stockholders of Bluegreen Corp. in the wake of a majority shareholder buyout, representing a 25% increase in total consideration to the minority shareholders.
$42M In re CNX Gas Corp. S’holder Litig., 4 A.3d 397 (Del. Ch. 2010)
As a member of Plaintiffs’ Executive Committee, we won a landmark ruling from the Delaware Court of Chancery establishing a unified standard for assessing the rights of shareholders in the context of freeze-out transactions, which ultimately led to a recovery of over $42.7 million for shareholders.